Cancer

Improving Cancer Outcomes for LGBTQ+ Patients Requires Earning Trust and Challenging Assumptions

PLYMOUTH MEETING, PA — The National Comprehensive Cancer Network® (NCCN®)—an alliance of leading cancer centers—recently hosted its annual NCCN Patient Advocacy Summit. This year’s dialogue was focused on sexual orientation and …

Improving Cancer Outcomes for LGBTQ+ Patients Requires Earning Trust and Challenging Assumptions Read More
National Comprehensive Cancer Network

New Study in JNCCN Presents Evidence for ‘Tough Conversations’ Around Racism in Access to Cancer Care

PLYMOUTH MEETING, PA — New research in the November 2022 issue of JNCCN—Journal of the National Comprehensive Cancer Network examined whether people with ovarian cancer were being treated based on very specific recommendations regarding comprehensive …

New Study in JNCCN Presents Evidence for ‘Tough Conversations’ Around Racism in Access to Cancer Care Read More

COVID-19

Bivalent Vaccines, Children with Cancer, and Other Developments: Latest COVID-19 Recommendations from NCCN

PLYMOUTH MEETING, PA — The National Comprehensive Cancer Network (NCCN—an alliance of leading cancer centers—recently released updated recommendations from the NCCN Advisory Committee on COVID-19 Vaccination and Pre-exposure Prophylaxis. This …

Bivalent Vaccines, Children with Cancer, and Other Developments: Latest COVID-19 Recommendations from NCCN Read More
Cancer

New Research for Borderline Resectable Locally Advanced Pancreatic Cancer Patients

PLYMOUTH MEETING, PA — New research in the September 2022 issue of JNCCN—Journal of the National Comprehensive Cancer Network finds the use of positron emission tomography (PET) with 18-fluorodeoxyglucose (FDG) tracer adds significant prognostic …

New Research for Borderline Resectable Locally Advanced Pancreatic Cancer Patients Read More